Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Dennis O'Brien

This page shows the latest Dennis O'Brien news and features for those working in and with pharma, biotech and healthcare.

Lucid Group acquires strategic brand consultants DiD

Lucid Group acquires strategic brand consultants DiD

DiD have a wealth of talent and have built amazing client relationships during the last 17 years,” said Dennis O’Brien, chief executive officer of Lucid Group.

Latest news

  • Lucid Group secures new investment from Intermediate Capital Group Lucid Group secures new investment from Intermediate Capital Group

    This marks the start of an exciting new chapter for Lucid, which drives increased investment to help us realise our vision of transforming lives,” said Dennis O’Brien, chief executive officer,

  • Lucid Group acquires HealthCare21 Lucid Group acquires HealthCare21

    Expands reach in UK, Asia Pacific and Middle East. From left to right: Cliff Wyatt, HealthCare21 managing director, Jan Steele, Lucid Group COO and co-founder and Dennis O’Brien, Lucid ... HealthCare21 brings further scientific and editorial expertise

  • Lucid Group acquires digital and creative agency Bluedog Lucid Group acquires digital and creative agency Bluedog

    Bluedog brings a “key piece of the jigsaw” to Lucid, commented Lucid’s CEO Dennis O’Brien, referring to the company’s skills in digital design, motion graphics, video development and ... a “perfect match” says O’Brien.

  • Signal strength Signal strength

    The best communications programmes start by identifying the patient outcomes they want to improve and work backwards from there,” says Dennis O’Brien, CEO, Lucid Group. ... says Dennis O’Brien.

  • The Communiqué Awards at 20: Dennis O’Brien The Communiqué Awards at 20: Dennis O’Brien

    Lucid's CEO on the Awards' enduring influence

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • The remote working revolution The remote working revolution

    The CEO Dennis O’Brien and management teams are really conscious about maintaining our distinct culture through this.”.

  • Mapping the patient journey and minding the gap Mapping the patient journey and minding the gap

    We’re on an evolutionary journey with patient-centricity,” said Dennis O’Brien, CEO, Lucid Group. ... That focus, said Dennis, presents a huge opportunity to broaden the scope of patient- centricity.

  • The social dilemma: is it time for pharma to join the party?

    Welcome to the world of social media in pharma, 2019-style. The words of Dennis O’Brien, CEO at Lucid Group, provide a mischievous metaphor to which we can all relate: ... The question is: why? Pay to party. Dennis O'Brien. “Pharma isn’t yet

  • The first, my last, my everything The first, my last, my everything

    It’s making progress, but there’s a long way to go. “We’ve got to get much closer to patients,” said Dennis O’Brien, CEO, Lucid Group. ... We need to get over it.”. Progress, said Dennis, may require a fundamental shift in mindset.

  • Measures for measures Measures for measures

    Pharma widely accepts that it struggles to measure digital marketing effectiveness – but perhaps it’s starting from the wrong place,” said Dennis O’Brien, CEO, Lucid Group. ... said Dennis O’Brien.

More from intelligence
Approximately 0 fully matching, plus 18 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 40 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Because health means everything...

Latest intelligence

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
...
New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...

Quick links